Balancing Risks in Developing a Personalised Approach to the Treatment of Early Hodgkin Lymphoma: A Haematologist's Perspective

Clin Oncol (R Coll Radiol). 2015 Aug;27(8):457-9. doi: 10.1016/j.clon.2015.05.008. Epub 2015 Jun 10.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / administration & dosage
  • Dacarbazine / administration & dosage
  • Doxorubicin / administration & dosage
  • Hodgkin Disease / drug therapy*
  • Hodgkin Disease / radiotherapy*
  • Humans
  • Precision Medicine
  • Radiation Injuries / prevention & control
  • Radiotherapy / adverse effects
  • Randomized Controlled Trials as Topic
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Dacarbazine
  • Doxorubicin
  • Cyclophosphamide